Bharat Immunologicals (India) Performance

BIBCL -- India Stock  

INR 8.83  0.33  3.88%

On a scale of 0 to 100 Bharat Immunologicals holds performance score of 5. The firm shows Beta (market volatility) of -0.0335 which signifies that as returns on market increase, returns on owning Bharat Immunologicals are expected to decrease at a much smaller rate. During bear market, Bharat Immunologicals is likely to outperform the market. Although it is vital to follow to Bharat Immunologicals historical returns, it is good to be conservative about what you can actually do with the information regarding equity current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. We have found twenty-one technical indicators for Bharat Immunologicals Biologicals Corp Ltd which you can use to evaluate performance of the firm. Please makes use of Bharat Immunologicals Jensen Alpha, Semi Variance and the relationship between Standard Deviation and Value At Risk to make a quick decision on weather Bharat Immunologicals price patterns will revert.
5

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Bharat Immunologicals Biologicals Corp Ltd are ranked lower than 5 (%) of all global equities and portfolios over the last 30 days. Despite somewhat uncertain basic indicators, Bharat Immunologicals sustained solid returns over the last few months and may actually be approaching a breakup point.
Fifty Two Week Low7.50
Fifty Two Week High27.15
Horizon     30 Days    Login   to change

Bharat Immunologicals Relative Risk vs. Return Landscape

If you would invest  801.00  in Bharat Immunologicals Biologicals Corp Ltd on March 20, 2019 and sell it today you would earn a total of  82.00  from holding Bharat Immunologicals Biologicals Corp Ltd or generate 10.24% return on investment over 30 days. Bharat Immunologicals Biologicals Corp Ltd is generating 0.5047% of daily returns and assumes 6.1806% volatility on return distribution over the 30 days horizon. Simply put, 55% of equities are less volatile than Bharat Immunologicals and 91% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming 30 trading days horizon, Bharat Immunologicals is expected to generate 10.61 times more return on investment than the market. However, the company is 10.61 times more volatile than its market benchmark. It trades about 0.08 of its potential returns per unit of risk. The DOW is currently generating roughly 0.12 per unit of risk.

Bharat Immunologicals Market Risk Analysis

Sharpe Ratio = 0.0817
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsBIBCL
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Bharat Immunologicals Relative Performance Indicators

Estimated Market Risk
 6.18
  actual daily
 
 55 %
of total potential
 
55
Expected Return
 0.5
  actual daily
 
 9 %
of total potential
 
9
Risk-Adjusted Return
 0.08
  actual daily
 
 5 %
of total potential
 
5
Based on monthly moving average Bharat Immunologicals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bharat Immunologicals by adding it to a well-diversified portfolio.

Bharat Immunologicals Alerts

Equity Alerts and Improvement Suggestions

Bharat Immunologicals appears to be very risky and stock price may revert if volatility continues
The company reported revenue of 347.2M. Net Loss for the year was (42.69M) with profit before overhead, payroll, taxes, and interest of 75.53M.
Check also Trending Equities. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.
Search macroaxis.com